CXCR3 and neoplasm: Overall, the results obtained in the adoptive transfer experiments confirm that the absence of CXCR3 does not impair CD4+ T-cell migration to MCA-induced tumours, and implies that the significant enrichment of CXCR3+ CD4+ T cells in tumours reflects their activation status and not preferential migration through the CXCR3 receptor.